Home532300 • BOM
add
Wockhardt Ltd
Previous close
₹1,190.15
Day range
₹1,149.05 - ₹1,199.10
Year range
₹275.30 - ₹1,334.55
Market cap
179.52B INR
Avg Volume
65.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 8.18B | 8.63% |
Operating expense | 4.37B | -2.67% |
Net income | -220.00M | 71.43% |
Net profit margin | -2.69 | 73.70% |
Earnings per share | — | — |
EBITDA | 1.38B | 92.36% |
Effective tax rate | -77.78% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.23B | 93.91% |
Total assets | 75.88B | 2.26% |
Total liabilities | 38.75B | -2.83% |
Total equity | 37.13B | — |
Shares outstanding | 149.66M | — |
Price to book | 5.25 | — |
Return on assets | — | — |
Return on capital | 3.48% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -220.00M | 71.43% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
Founded
1967
Website
Employees
2,386
